MAPK Signaling Pathways in Hepatic Ischemia/Reperfusion Injury
DOI: https://doi.org/10.2147/JIR.S396604
IF: 4.5
2023-03-28
Journal of Inflammation Research
Abstract:Bo Yu, &ast Yalong Zhang, &ast Tianyu Wang, Jiayu Guo, Chenyang Kong, Zhongbao Chen, Xiaoxiong Ma, Tao Qiu Department of Organ Transplantation, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Tao Qiu, Department of Organ Transplantation, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, People's Republic of China, Tel +86-13995632367, Email The mitogen-activated protein kinase signaling pathway can be activated by a variety of growth factors, cytokines, and hormones, and mediates numerous intracellular signals related to cellular activities, including cell proliferation, motility, and differentiation. It has been widely studied in the occurrence and development of inflammation and tumor. Hepatic ischemia-reperfusion injury (HIRI) is a common pathophysiological phenomenon that occurs in surgical procedures such as lobectomy and liver transplantation, which is characterized by severe inflammatory reaction after ischemia and reperfusion. In this review, we mainly discuss the role of p38, ERK1/2, JNK in MAPK family and TAK1 and ASK1 in MAPKKK family in HIRI, and try to find an effective treatment for HIRI. Keywords: ischemia/reperfusion injury, mitogen-activated protein kinases, liver Signal transduction by mitogen activated protein kinase (MAPK) is carried out in a three-level cascade. That is, the kinase of MAPKK kinase (MAPKKK) phosphorylates and activates MAPK kinase (MAPKK), then phosphorylates MAPK to activate it, and then translocates to the nucleus to regulate the basic physiological processes of cells. 1 MAPKs are a group of highly conserved serine/threonine protein kinases that control cellular activity via signal transduction, substitution, amplification, and integration. 2 Dozens of members of the MAPKs family have been identified so far, and the role of apoptosis signal-regulating kinase 1(ASK1) and transforming growth factor β-activated kinase 1 (TAK1) of the MAP3K family in hepatic ischemia-reperfusion injury is increasingly studied in HIR. 3–7 MAPKKK acts on MAPKK to phosphorylate and activate it. Activated MAPKK then acts on MAPK family signaling molecules to phosphorylate and activate it. Activated MAPK enters the nucleus to regulate transcriptional regulation. We pay more attention to the function of extracellular signal regulated kinase 1 / 2 (ERK1 / 2), c-Jun N-terminal kinase (JNK) and p38MAPK in HIRI. Hepatic ischemia/reperfusion injury (HIRI) includes "cold" IRI and "warm" IRI (which is very common in liver transplantation). 8–10 HIRI mainly involves hepatocytes, Kupffer cells (KCs) and immune cells including t cells and monocytes. The pathophysiological process is biphasic: initial ischemic liver injury and reperfusion injury after restoration of the blood supply. 11–14 During initial ischemic liver injury, blood flow into the liver is blocked, which results in local ischemia. The latter leads to hepatic hypoxia, consumption of adenosine triphosphate and glycogen, mitochondrial dysfunction and, eventually, hepatocyte necrosis. 15,16 Large numbers of inflammatory cells such as neutrophils, KCs, dendritic cells, circulating lymphocytes and monocytes infiltrate and accumulate in the damaged area. This action leads to the activation and secretion of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and other proinflammatory factors, which results in inflammatory reactions and direct damage to hepatocytes. 17,18 After restoration of the blood supply, activated KCs release many proinflammatory factors, which activate neutrophils and T cells further, and aggravate tissue damage. 19,20 Monocytes in the blood circulation are activated by proinflammatory factors and differentiate into macrophages with similar function to KCs, and are then recruited to the liver to maintain the immune response and amplify the inflammatory response further, which aggravates liver injury. IRI-mediated hepatocyte injury in a donor liver leads to poor liver function and acute/chronic rejection after transplantation, which limits clinical application of the donor liver. 19,21 The mechanism of HIRI stated above involves cytokines and mediators, which are related to several cellular pathways (Figure 1). 13,22–24 If HIRI occurs, then p38, JNK and ERK are activated by specific cells to elicit a series of physiological and pathological reactions. 2,7,25 Therefore, these MAPK-related molecules are considered to be potential therapeutic targets for HIRI. Figure 1 MAPK-related signaling pathways involved in hepatic ischemia-reperfusion injury. p38, Jnk and ERK participate in the regulation of liver ischemia-reperfusion injury throu -Abstract Truncated-
immunology